These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 8041988

  • 1. [Small cell bronchial cancer. Comparison of results of weekly polychemotherapy using multiple drugs with standard chemotherapy. European Lung Cancer Working Party].
    Sculier JP, Paesmans M, Bureau G, Dabouis G, Libert P, Vandermoten G, Van Cutsem O, Berchier MC, Ries F, Michel J.
    Rev Mal Respir; 1994; 11(3):257-61. PubMed ID: 8041988
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586).
    Yuen AR, Fuks JZ, Ettinger DS, Chang AY, Ruckdeschel JC, Phan SC, Blum RH.
    Cancer J Sci Am; 2000; 6(1):34-9. PubMed ID: 10696737
    [Abstract] [Full Text] [Related]

  • 4. A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics.
    Sculier JP, Paesmans M, Lecomte J, Van Cutsem O, Lafitte JJ, Berghmans T, Koumakis G, Florin MC, Thiriaux J, Michel J, Giner V, Berchier MC, Mommen P, Ninane V, Klastersky J, European Lung Cancer Working Party.
    Br J Cancer; 2001 Nov 16; 85(10):1444-51. PubMed ID: 11720426
    [Abstract] [Full Text] [Related]

  • 5. [Chemotherapy of small cell lung cancer].
    Komiya T, Takada M.
    Gan To Kagaku Ryoho; 1996 Aug 16; 23(9):1116-23. PubMed ID: 8751797
    [Abstract] [Full Text] [Related]

  • 6. [Progress and obstacles in chemotherapy and combined modality treatment of small cell lung cancer].
    Ohnoshi T, Ueoka H, Numata T, Kawahara S, Nishii K, Yonei T, Mima Y, Horiguchi T, Kiura K, Moritaka T.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Feb 16; 28(2):190-6. PubMed ID: 2162437
    [Abstract] [Full Text] [Related]

  • 7. Combination chemotherapy for small cell lung cancer.
    Sufarlan AW, Zainudin BM.
    Med J Malaysia; 1993 Jun 16; 48(2):166-70. PubMed ID: 8394502
    [Abstract] [Full Text] [Related]

  • 8. [Pilot study of dose intensive weekly chemotherapy followed by cisplatin plus etoposide with concurrent thoracic irradiation for limited-disease small-cell lung cancer. West Japan Thoracic Oncology Group].
    Isobe T, Fukuoka M, Negoro S, Sugiura T, Kawahara M, Kudoh S, Araki J, Nakagawa K, Yokozaki M, Yamakido M, Ariyoshi Y.
    Gan To Kagaku Ryoho; 2000 Jul 16; 27(8):1091-6. PubMed ID: 10945001
    [Abstract] [Full Text] [Related]

  • 9. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S, Bremnes RM, Kaasa S, Aasebø U, Aamdal S, Norwegian Lung Cancer Study Group.
    Lung Cancer; 2005 May 16; 48(2):251-61. PubMed ID: 15829326
    [Abstract] [Full Text] [Related]

  • 10. Induction chemotherapy with ifosfamide, etoposide, and anthracycline for small cell lung cancer: experience of the European Lung Cancer Working Party.
    Sculier JP, Bureau G, Giner V, Thiriaux J, Michel J, Berchier MC, Van Cutsem O, Küstner U, Kroll F, Mommen P.
    Semin Oncol; 1995 Feb 16; 22(1 Suppl 2):18-22. PubMed ID: 7846537
    [Abstract] [Full Text] [Related]

  • 11. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.
    Spiro SG, James LE, Rudd RM, Trask CW, Tobias JS, Snee M, Gilligan D, Murray PA, Ruiz de Elvira MC, O'Donnell KM, Gower NH, Harper PG, Hackshaw AK, London Lung Cancer Group.
    J Clin Oncol; 2006 Aug 20; 24(24):3823-30. PubMed ID: 16921033
    [Abstract] [Full Text] [Related]

  • 12. A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: results of long term follow-up.
    Ueoka H, Kiura K, Tabata M, Kamei H, Gemba K, Sakae K, Hiraki Y, Hiraki S, Segawa Y, Harada M.
    Cancer; 1998 Jul 15; 83(2):283-90. PubMed ID: 9669811
    [Abstract] [Full Text] [Related]

  • 13. [Antineoplastic chemotherapy for bronchial carcinoma].
    Tanneberger S.
    Arch Geschwulstforsch; 1985 Jul 15; 55(1):63-71. PubMed ID: 2985017
    [Abstract] [Full Text] [Related]

  • 14. [Adriamycin, cyclophosphamide, vincristine and methotrexate combination chemotherapy of small cell lung cancer].
    Saito H, Kawatsu H, Saka H, Yamamoto M, Takagi E, Tsunekawa H, Kawachi H, Nagura E, Sakai S, Nishiwaki K.
    Gan To Kagaku Ryoho; 1988 Jun 15; 15(6):1909-13. PubMed ID: 2838000
    [Abstract] [Full Text] [Related]

  • 15. The importance of dose and dose intensity in lung cancer chemotherapy.
    Murray N.
    Semin Oncol; 1987 Dec 15; 14(4 Suppl 4):20-8. PubMed ID: 2825357
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of lung cancer--state of the art in 2000].
    Nakanishi Y, Inoue K, Hara N.
    Gan To Kagaku Ryoho; 2000 Jul 15; 27(8):1247-52. PubMed ID: 10945023
    [Abstract] [Full Text] [Related]

  • 17. Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexate, vincristine and lomustine. Swiss Group for Clinical Cancer Research (SAKK).
    Joss RA, Alberto P, Hürny C, Bacchi M, Leyvraz S, Thürlimann B, Cerny T, Martinelli G, Stahel R, Ludwig C.
    Ann Oncol; 1995 Jan 15; 6(1):41-8. PubMed ID: 7536028
    [Abstract] [Full Text] [Related]

  • 18. Dose-intensive chemotherapy in extensive-stage small cell lung cancer.
    Fukuoka M, Masuda N, Takada M, Kodama N, Kawahara M, Furuse K.
    Semin Oncol; 1994 Feb 15; 21(1 Suppl 1):43-7. PubMed ID: 7512276
    [No Abstract] [Full Text] [Related]

  • 19. Results of chemo-radiotherapy and prognostic factors of small cell lung cancer.
    Shikaura S, Kawa S, Yoshida M, Yonezu S.
    Radiat Med; 1991 Feb 15; 9(2):70-6. PubMed ID: 1658856
    [Abstract] [Full Text] [Related]

  • 20. [Long-term results of small cell lung cancer treated by surgery combined with postoperative chemotherapy: a report of 65 patients].
    Zhang X, Sun Y, Huang J.
    Zhonghua Zhong Liu Za Zhi; 1997 Mar 15; 19(2):137-9. PubMed ID: 10743080
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.